glp 1 agonist diabetes Frontiers GLP1-GIP receptor co-agonists: a promising

V.et al (2022)

Liraglutide suppresses obesity and induces brown fat-like phenotype via soluble guanylyl cyclase mediated pathway in vivo andin vitro

Moreover, GLP-1R activation counteracts the effects of -adrenoceptor stimulation on cardiac ventricular excitability and reduces ventricular arrhythmic potential [165]

Emerging data also suggest that GLP-1 drugs may reprogram certain cells in different organs, which could help explain why we see effects across multiple aging clocks, said Corley

[DOI] [PubMed] [Google Scholar] 66.Kim S-J, Winter K, Nian C, et al

Inflammation in atherosclerosis: from pathophysiology to practice